BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17727978)

  • 1. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
    Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
    Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
    Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
    O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
    J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system.
    Auliff AM; Adams JH; O'Neil MT; Cheng Q
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3927-32. PubMed ID: 20566761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
    Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
    Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
    Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
    Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.
    Kaur S; Prajapati SK; Kalyanaraman K; Mohmmed A; Joshi H; Chauhan VS
    Acta Trop; 2006 Feb; 97(2):174-80. PubMed ID: 16310156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs.
    Djapa LY; Zelikson R; Delahodde A; Bolotin-Fukuhara M; Mazabraud A
    FEMS Microbiol Lett; 2006 Mar; 256(1):105-11. PubMed ID: 16487326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
    Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
    Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
    Hastings MD; Maguire JD; Bangs MJ; Zimmerman PA; Reeder JC; Baird JK; Sibley CH
    Antimicrob Agents Chemother; 2005 Feb; 49(2):733-40. PubMed ID: 15673758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
    Hastings MD; Porter KM; Maguire JD; Susanti I; Kania W; Bangs MJ; Sibley CH; Baird JK
    J Infect Dis; 2004 Feb; 189(4):744-50. PubMed ID: 14767830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
    Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
    Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli.
    Tahar R; de Pécoulas PE; Basco LK; Chiadmi M; Mazabraud A
    Mol Biochem Parasitol; 2001 Apr; 113(2):241-9. PubMed ID: 11295178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.
    Garg S; Saxena V; Lumb V; Pakalapati D; Boopathi PA; Subudhi AK; Chowdhury S; Kochar SK; Kochar DK; Sharma YD; Das A
    Exp Parasitol; 2012 Dec; 132(4):410-6. PubMed ID: 23043980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia.
    de Pécoulas PE; Tahar R; Yi P; Thai KH; Basco LK
    Acta Trop; 2004 Sep; 92(1):1-6. PubMed ID: 15301969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine resistance.
    Tahar R; Basco LK
    Am J Trop Med Hyg; 2007 Aug; 77(2):221-7. PubMed ID: 17690390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
    Cortese JF; Plowe CV
    Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.